One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
FLASH Radiotherapy & Particle Therapy conference, FRPT2021
Marie-CatherineVozeninaAndreasSchüllerbMarieDutreixcdKarenKirkbyeMichaelBaumannfRob P.CoppesgDavidThwaiteshi
doi : 10.1016/j.radonc.2022.09.013
Volume 175, October 2022, Pages 167-168
Combining FLASH and spatially fractionated radiation therapy: The best of both worlds
TimSchneiderab1CristianFernandez-Palomoc1AnnaïgBerthoabJenniferFazzaricLoreaIturriabOlga A.MartincdeVerdianaTrappetticValentinDjonovcYolandaPrezadoab
doi : 10.1016/j.radonc.2022.08.004
Volume 175, October 2022, Pages 169-177
Pencil beam scanning proton FLASH maintains tumor control while normal tissue damage is reduced in a mouse model
Brita SingersSørensenabMateusz KrzysztofSitarzaChristinaAnkjærgaardcJacob G.JohansenaClaus E.AndersencEleniKanoutaaCaiGrauaPerPoulsenad
doi : 10.1016/j.radonc.2022.05.014
Volume 175, October 2022, Pages 178-184
FLASH with carbon ions: Tumor control, normal tissue sparing, and distal metastasis in a mouse osteosarcoma model
WalterTinganelliaUliWeberaAnggraeiniPuspitasariaPalmaSimoniellobAmirAbdollahicJuliusOppermannaChristophSchuyaFelixHorstaAlexanderHelmaClaudiaFournieraMarcoDurantead
doi : 10.1016/j.radonc.2022.05.003
Volume 175, October 2022, Pages 185-190
Commentary on the article: Sørensen BS et al., Pencil beam scanning proton FLASH maintains tumor control while normal tissue damage is reduced in a mouse model
Ludwig J.Dubois
doi : 10.1016/j.radonc.2022.08.012
Volume 175, October 2022, Pages 191-192
Changes in Radical Levels as a Cause for the FLASH effect: Impact of beam structure parameters at ultra-high dose rates on oxygen depletion in water
JeannetteJansenaElkeBeyreutherbcDanielGarcÃa-CalderónadLeonhardKarschbeJanKnolladJörgPawelkebeMichaelSchürerfJoaoSecoad
doi : 10.1016/j.radonc.2022.08.024
Volume 175, October 2022, Pages 193-196
Comparing radiolytic production of H2O2 and development of Zebrafish embryos after ultra high dose rate exposure with electron and transmission proton beams
HoudaKacemaSerenaPsoroulasbGaelBoivincMichaelFolkertscVeljkoGriljdTonyLomaxbdAdrienMartinottiaDavidMeerbJonathanOllivieraBenoitPetitaSairosSafaibRicky A.SharmacMicheleTognobMartaVilaltacDamien C.WeberbMarie-CatherineVozenina
doi : 10.1016/j.radonc.2022.07.011
Volume 175, October 2022, Pages 197-202
Design and validation of a dosimetric comparison scheme tailored for ultra-high dose-rate electron beams to support multicenter FLASH preclinical studies
Patrik GonçalvesJorgebStavrosMelemenidiscVeljkoGriljbThierryBuchillierbRakeshManjappacVigneshViswanathancMaudeGondrébMarie-CatherineVozeninaJean-FrançoisGermondbFrançoisBochudbRaphaëlMoecklibCharlesLimolieLawrieSkinnercHyunsoo JoshuaNocYufan FredWucMuratSurucucAmy S.YucBriannaLauc…ClaudeBailatb
doi : 10.1016/j.radonc.2022.08.023
Volume 175, October 2022, Pages 203-209
FLASH radiotherapy treatment planning and models for electron beams
MahbuburRahmana1AntonioTrigiliobc1GaiaFranciosinibcRaphaëlMoecklidRongxiaoZhangaeTill TobiasBöhlend
doi : 10.1016/j.radonc.2022.08.009
Volume 175, October 2022, Pages 210-221
Treatment planning considerations for the development of FLASH proton therapy
BethanyRothwella1MatthewLoweba1ErikTraneusc1MiriamKriegerd1JanSchuemanne1
doi : 10.1016/j.radonc.2022.08.003
Volume 175, October 2022, Pages 222-230
Trade-off in healthy tissue sparing of FLASH and fractionation in stereotactic proton therapy of lung lesions with transmission beams
StevenHabrakenab1SebastiaanBreedveldaJortGroena2JoostNuyttensacMischaHoogemanab
doi : 10.1016/j.radonc.2022.08.015
Volume 175, October 2022, Pages 231-237
Advanced pencil beam scanning Bragg peak FLASH-RT delivery technique can enhance lung cancer planning treatment outcomes compared to conventional multiple-energy proton PBS techniques
ShouyiWeiaHaiboLina1J.Isabelle ChoiaChengyuShibCharles B.SimoneIIa1MingleiKanga
doi : 10.1016/j.radonc.2022.08.005
Volume 175, October 2022, Pages 238-247
Assessing the role of radiotherapy in patients with refractory or relapsed high-grade B-cell lymphomas treated with CAR T-cell therapy
Hazim S.AbabnehaJeremy S.AbramsonbP. ConnorJohnsonbChirayu G.Patela
doi : 10.1016/j.radonc.2022.08.007
Volume 175, October 2022, Pages 65-72
A systematic review of clinical studies on variable proton Relative Biological Effectiveness (RBE)
Tracy S.A.UnderwoodabAimee L.McNamaracAneAppeltdeJoanne S.HavilandfBrita SingersSørensenghEsther G.C.Troostijklmn
doi : 10.1016/j.radonc.2022.08.014
Volume 175, October 2022, Pages 79-92
Systematic review of adjuvant external beam radiotherapy for hepatocellular carcinoma following radical hepatectomy
LeiWanga1LuQiub1QiaoKec1HongbingJidJunxinWua
doi : 10.1016/j.radonc.2022.08.019
Volume 175, October 2022, Pages 101-111
H&N and Skin (HNS) GEC-ESTRO Working Group critical review of recommendations regarding prescription depth, bolus thickness and maximum dose in skin superficial brachytherapy with flaps and customized moulds
VictorGonzalez-PerezaAgataRembielakbcJose LuisGuinotdRaminJaberieValentinaLancellottafRenateWaltergAnysjaZuchorahAshwiniBudrukkariGyörgyKovácsjInaJürgenliemk-SchulzkFrank-AndréSiebertlLucaTagliaferrif
doi : 10.1016/j.radonc.2022.08.022
Volume 175, October 2022, Pages 122-132
Impact on xerostomia for nasopharyngeal carcinoma patients treated with superficial parotid lobe-sparing intensity-modulated radiation therapy (SPLS-IMRT): A prospective phase II randomized controlled study
HuagengHuanga1JingjingMiaoa1XiaoXiaoa1JiangHubGuangshunZhangbYinglinPengbShunzhenLuaYingshanLiangaShaominHuangbFeiHanbXiaowuDengbChongZhaoaLinWanga
doi : 10.1016/j.radonc.2022.07.006
Volume 175, October 2022, Pages 1-9
Quantifying the post-radiation accelerated brain aging rate in glioma patients with deep learning
Selena I.HuismanaArthur T.J.van der BoogaFiaCialdellaabJoost J.C.VerhoeffaSzabolcsDavida
doi : 10.1016/j.radonc.2022.08.002
Volume 175, October 2022, Pages 18-25
Development and validation of a prognostic gene expression signature for lower-grade glioma following surgery and adjuvant radiotherapy
David C.QianaJoseph A.MarasciobRachelTobilloaJoshua W.LorenzaNeal S.McCallaStewart G.NeillcKimberly B.HoangdJeffrey J.OlsondBree R.EatonaHui-Kuo G.ShuaJimZhonga
doi : 10.1016/j.radonc.2022.08.020
Volume 175, October 2022, Pages 93-100
Iatrogenic influence on prognosis of radiation-induced contrast enhancements in patients with glioma WHO 1–3 following photon and proton radiotherapy
TanjaEichkornabceJonathan W.LischalkgElisabettaSandriniabceEvaMeixnerabceSebastianRegneryabceThomasHeldabceJuliaBauerabeEmanuelBahndSemiHarrabiabceJulianeHörner-RieberabcdefKlausHerfarthabceJürgenDebusabcdefLailaKönigabce
doi : 10.1016/j.radonc.2022.08.025
Volume 175, October 2022, Pages 133-143
Prognostic significance of lab data and performance comparison by validating survival prediction models for patients with spinal metastases after radiotherapy
Hung-KuanYenabc1Ming-HsiaoHua1HesterZijlstradeOlivier Q.GrootdeHsiang-ChiehHsiehbJiun-JenYangaAditya V.KarhadeePo-ChaoChenaYu-HanChenaPo-HaoHuangaYu-HungChenaFu-RenXiaofJorrit-JanVerlaandJoseph H.SchwabeRong-SenYangaShu-HuaYangaWei-HsinLinaFeng-MingHsughi
doi : 10.1016/j.radonc.2022.08.029
Volume 175, October 2022, Pages 159-166
Simulated computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR) for the treatment of locally advanced pancreatic cancer
Joshua P.Schiffa†Alex T.Pricea†Hayley B.StoweaEricLaugemanaRe-IChinaCaseyHatscheraEleanorPryseraBinCaibGeoffrey D.HugoaHyunKimaShahed N.BadiyanaClifford G.RobinsonaLauren E.Henkea
doi : 10.1016/j.radonc.2022.08.026
Volume 175, October 2022, Pages 144-151
Evaluation of risk-tailored individualized selection of radiation therapy target volume for head and neck carcinoma of unknown primary
HamzaGhatashehaShao HuiHuangaJieSuc1WeiXuc1Scott V.BratmanaJohnChoaMeredithGiulianiaEzraHahnaAndrewHopeaJohnKimaBrianO'SullivanaJolieRingashaJohnWaldronaDouglas B.ChepehabJonathan C.IrishbDavid P.GoldsteinbAnnaSpreaficodLiTonga…AliHosnia
doi : 10.1016/j.radonc.2022.07.016
Volume 175, October 2022, Pages 56-64
Organs at risk dose constraints in carbon ion radiotherapy at MedAustron: Translations between LEM and MKM RBE models and preliminary clinical results
SarahGrosshagauerabPieroFossatiaMansureSchafasandacAntonioCarlinoaKarinPoljancbTobiasRadakovitsbMarkusStockaEugenHugaPetraGeorgaMaciejPelakaJoannaGóraa
doi : 10.1016/j.radonc.2022.08.008
Volume 175, October 2022, Pages 73-78
Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer
Reinout H.de RoestaMartijnvan der HeijdenbcFrederik W.R.WesselingdEmma J.de RuitereMartijn W.HeymansfChrisTerhaardgMarije R.VergeerhJanButeriLot A.DevriesejJan Paulde BoerkArashNavranlAnnHoebendmConchitaVensbclMichielvan den BrekelbnRuud H.BrakenhoffaC. RenéLeemansaFrankHoebersd
doi : 10.1016/j.radonc.2022.08.013
Volume 175, October 2022, Pages 112-121
A traffic light protocol workflow for image-guided adaptive radiotherapy in lung cancer patients
DjoyaHattuJoleinMannensMichelÖllersJudithvan LoonDirkDe RuysscherWoutervan Elmpt
doi : 10.1016/j.radonc.2022.08.030
Volume 175, October 2022, Pages 152-158
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation
CesareCozzariniaMichelaOlivieribAlessandroMaglicDomenicoCantedBarbaraNoris ChiordaeFernandoMunozfAdrianaFaiellagElisaOlivettahChiaraDeantoniaAndreiFodoraMarco AndreaSignorcEdoardoPetruccidBarbaraAvuzzieLetiziaFerellafAlicePastorinohElisabettaGaribaldiiMarcoGattiiLucianaRagoj…ClaudioFiorinob
doi : 10.1016/j.radonc.2022.08.001
Volume 175, October 2022, Pages 26-32
Palliative radiotherapy in cancers of female genital tract: Outcomes and prognostic factors
Sri HarshaKombathulaaAntheaCreeabPriya V.JoshidNesrinAkturkaLisa H.BarracloughaKateHaslettaAnanyaChoudhuryacPeterHoskinacd
doi : 10.1016/j.radonc.2022.07.023
Volume 175, October 2022, Pages 42-46
Knowledge-based multi-institution plan prediction of whole breast irradiation with tangential fields
AlessiaTuddaabRobertaCastriconiaGiovannaBenecchicElisabettaCagnidAlessandroCicchettieFrancescaDusifPier GiorgioEspositoaMarikaGuernierigAnnaIanirohValeriaLandonihAldoMazzillicEugeniaMorettigCaterinaOlivieroiLorenzoPlacidijGiuliaRambaldi GuidascikTizianaRancatieAlessandroScaggionfValeriaTrojanidClaudioFiorinoa
doi : 10.1016/j.radonc.2022.07.012
Volume 175, October 2022, Pages 10-16
In vivo assessment of tissue-specific radiological parameters with intra- and inter-patient variation using dual-energy computed tomography
NilsPetersabAaronKieslichabPatrickWohlfahrtab1ChristianHofmanncChristianRichterabde
doi : 10.1016/j.radonc.2022.07.021
Volume 175, October 2022, Pages 34-41
A case-control study of linear energy transfer and relative biological effectiveness related to symptomatic brainstem toxicity following pediatric proton therapy
Lars FredrikFjæraaDaniel J.IndelicatobAndreas H.HandelandacKristian S.Ytre-HaugeaYasminLassen-RamshaddLudvig P.MurendeCamilla H.Stokkevågac
doi : 10.1016/j.radonc.2022.07.022
Volume 175, October 2022, Pages 47-55
A neuropathic component of tumor-related pain as a predictor of good response to palliative radiotherapy
TetsuoSaitoaNaokiNakamurabNatsuoOyac
doi : 10.1016/j.radonc.2022.08.006
Volume 175, October 2022, Page 17
High dose rate brachytherapy for anal cancer: A review of a systematic review
RonaldChowabCharles B.SimoneIIa
doi : 10.1016/j.radonc.2022.08.010
Volume 175, October 2022, Page 33
